CNBT
TEVA icon

Canandaigua National Bank & Trust’s Teva Pharmaceuticals TEVA Stock Holding History

Canandaigua National Bank & Trust’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-11,749
Closed -$390K – 245
2017
Q2 		$390K Sell
11,749
-3,455
-23% -$107K 0.08% 177
2017
Q1 		$486K Sell
15,204
-607
-4% -$20.7K 0.14% 130
2016
Q4 		$572K Sell
15,811
-64
-0.4% -$2.56K 0.17% 113
2016
Q3 		$730K Buy
15,875
+230
+1% +$12K 0.21% 102
2016
Q2 		$786K Sell
15,645
-1,425
-8% -$75.9K 0.22% 101
2016
Q1 		$913K Sell
17,070
-115
-0.7% -$6.75K 0.27% 93
2015
Q4 		$1.13M Sell
17,185
-200
-1% -$12.4K 0.34% 80
2015
Q3 		$982K Sell
17,385
-565
-3% -$36.6K 0.31% 83
2015
Q2 		$1.06M Sell
17,950
-220
-1% -$13.6K 0.31% 82
2015
Q1 		$1.13M Buy
18,170
+4,194
+30% +$244K 0.34% 78
2014
Q4 		$804K Sell
13,976
-190
-1% -$10.6K 0.26% 93
2014
Q3 		$761K Sell
14,166
-13,600
-49% -$721K 0.25% 91
2014
Q2 		$1.46M Sell
27,766
-943
-3% -$48.2K 0.48% 51
2014
Q1 		$1.52M Buy
28,709
+3,318
+13% +$153K 0.51% 51
2013
Q4 		$1.02M Sell
25,391
-6,126
-19% -$241K 0.36% 71
2013
Q3 		$1.19M Sell
31,517
-8,282
-21% -$323K 0.45% 57
2013
Q2 		$1.56M Buy
+39,799
New +$1.55M 0.61% 47

Other funds holding TEVA

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Canandaigua National Bank & Trust's TEVA Position: Q3 2017 in Review

Canandaigua National Bank & Trust sold out of Teva Pharmaceuticals (TEVA) in Q3 2017, closing a stake of 11,749 shares — an estimated $390K sold.

Canandaigua National Bank & Trust first reported a position in TEVA in Q2 2013 and held it in 17 quarters. The position peaked at $1.56M in Q2 2013. 536 funds tracked by Wall St. Rank hold TEVA as of Q3 2017.

  • Canandaigua National Bank & Trust reported no remaining Teva Pharmaceuticals position as of Q3 2017 after selling out during the quarter.
  • Canandaigua National Bank & Trust sold 11,749 Teva Pharmaceuticals shares in Q3 2017, an estimated $390K.
  • Canandaigua National Bank & Trust first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 17 quarters.
  • Canandaigua National Bank & Trust's Teva Pharmaceuticals position peaked at $1.56M in Q2 2013.
  • 536 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2017.

Based on Canandaigua National Bank & Trust's 13F filing for Q3 2017, filed 6 Oct 2017.